APO Research
Talk to an analyst

APO RESEARCH · REPORT

Prescription Arthritis Medications

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Prescription Arthritis Medications Industry Growth and Trends Forecast to 2032

22 December 202593 pages

Choose your research edition.

Industry ResearchPrescription Arthritis Medications Industry Research Report 2026118 pages · $2,950 USDIndustry Growth & TrendsGlobal Prescription Arthritis Medications Industry Growth and Trends Forecast to 203293 pages · $3,450 USDMarket StructureGlobal Prescription Arthritis Medications Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032185 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Prescription Arthritis Medications Market Outlook and Growth Opportunities 2026193 pages · $4,250 USDMarket Analysis & ForecastGlobal Prescription Arthritis Medications Market Analysis and Forecast 2026-2032197 pages · $4,950 USD

Market perspective

The global Prescription Arthritis Medications market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Prescription Arthritis Medications is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Prescription Arthritis Medications is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Prescription Arthritis Medications is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Prescription Arthritis Medications include Boehringer Ingelheim, Horizon Pharma, Amgen, Pfizer, Novartis, Abbott and Regeneron, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Prescription Arthritis Medications market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Prescription Arthritis Medications market size, estimates, and forecasts are presented in terms of sales volume (k units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Prescription Arthritis Medications market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Prescription Arthritis Medications.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Prescription Arthritis Medications market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Prescription Arthritis Medications Market by Company

Boehringer Ingelheim

Horizon Pharma

Amgen

Pfizer

Novartis

Abbott

Regeneron

Prescription Arthritis Medications Segment by Type

Oral

Topical

Prescription Arthritis Medications Segment by Application

Online Pharmacies

Hospital Pharmacies

Retail Pharmacies

Prescription Arthritis Medications Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Prescription Arthritis Medications market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Prescription Arthritis Medications and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Prescription Arthritis Medications.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Prescription Arthritis Medications manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Prescription Arthritis Medications in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Oral Table 2. Major Company of Topical Table 3. Global Prescription Arthritis Medications Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Prescription Arthritis Medications Sales by Type (2021-2026) & (k units) Table 5. Global Prescription Arthritis Medications Sales Market Share in Volume by Type (2021-2026) Table 6. Global Prescription Arthritis Medications Sales by Type (2021-2026) & (US$ Million) Table 7. Global Prescription Arthritis Medications Sales Market Share in Value by Type (2021-2026) Table 8. Global Prescription Arthritis Medications Price by Type (2021-2026) & (US$/unit) Table 9. Global Prescription Arthritis Medications Sales by Type (2027-2032) & (k units) Table 10. Global Prescription Arthritis Medications Sales Market Share in Volume by Type (2027-2032) Table 11. Global Prescription Arthritis Medications Sales by Type (2027-2032) & (US$ Million) Table 12. Global Prescription Arthritis Medications Sales Market Share in Value by Type (2027-2032) Table 13. Global Prescription Arthritis Medications Price by Type (2027-2032) & (US$/unit) Table 14. North America Prescription Arthritis Medications Sales by Type (2021-2026) & (k units) Table 15. North America Prescription Arthritis Medications Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Prescription Arthritis Medications Sales by Type (2021-2026) & (k units) Table 17. Europe Prescription Arthritis Medications Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Prescription Arthritis Medications Sales by Type (2021-2026) & (k units) Table 19. Asia-Pacific Prescription Arthritis Medications Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Prescription Arthritis Medications Sales by Type (2021-2026) & (k units) Table 21. Latin America Prescription Arthritis Medications Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Prescription Arthritis Medications Sales by Type (2021-2026) & (k units) Table 23. Middle East and Africa Prescription Arthritis Medications Sales by Type (2021-2026) & (US$ Million) Table 24. Prescription Arthritis Medications Industry Trends Table 25. Prescription Arthritis Medications Industry Drivers Table 26. Prescription Arthritis Medications Industry Opportunities and Challenges Table 27. Prescription Arthritis Medications Industry Restraints Table 28. Global Prescription Arthritis Medications Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Prescription Arthritis Medications Revenue Market Share by Company (2021-2026) Table 30. Global Prescription Arthritis Medications Sales by Company (2021-2026) & (k units) Table 31. Global Prescription Arthritis Medications Sales Share by Company (2021-2026) Table 32. Global Prescription Arthritis Medications Market Price by Company (2021-2026) & (US$/unit) Table 33. Global Prescription Arthritis Medications Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Prescription Arthritis Medications Major Company Production Sites and Headquarters Table 35. Global Prescription Arthritis Medications Company, Product Type & Application Table 36. Global Prescription Arthritis Medications Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Prescription Arthritis Medications by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Prescription Arthritis Medications Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Prescription Arthritis Medications Sales by Region (2021-2026) & (k units) Table 41. Global Prescription Arthritis Medications Sales Market Share in Volume by Region (2021-2026) Table 42. Global Prescription Arthritis Medications Sales by Region (2021-2026) & (US$ Million) Table 43. Global Prescription Arthritis Medications Sales Market Share in Value by Region (2021-2026) Table 44. Global Prescription Arthritis Medications Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 45. Global Prescription Arthritis Medications Sales by Region (2027-2032) & (k units) Table 46. Global Prescription Arthritis Medications Sales Market Share in Volume by Region (2027-2032) Table 47. Global Prescription Arthritis Medications Sales by Region (2027-2032) & (US$ Million) Table 48. Global Prescription Arthritis Medications Sales Market Share in Value by Region (2027-2032) Table 49. Global Prescription Arthritis Medications Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2027-2032) Table 50. Global Prescription Arthritis Medications Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Prescription Arthritis Medications Sales by Application (2021-2026) & (k units) Table 52. Global Prescription Arthritis Medications Sales Market Share in Volume by Application (2021-2026) Table 53. Global Prescription Arthritis Medications Sales by Application (2021-2026) & (US$ Million) Table 54. Global Prescription Arthritis Medications Sales Market Share in Value by Application (2021-2026) Table 55. Global Prescription Arthritis Medications Price by Application (2021-2026) & (US$/unit) Table 56. Global Prescription Arthritis Medications Sales by Application (2027-2032) & (k units) Table 57. Global Prescription Arthritis Medications Sales Market Share in Volume by Application (2027-2032) Table 58. Global Prescription Arthritis Medications Sales by Application (2027-2032) & (US$ Million) Table 59. Global Prescription Arthritis Medications Sales Market Share in Value by Application (2027-2032) Table 60. Global Prescription Arthritis Medications Price by Application (2027-2032) & (US$/unit) Table 61. North America Prescription Arthritis Medications Sales by Application (2021-2026) & (k units) Table 62. North America Prescription Arthritis Medications Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Prescription Arthritis Medications Sales by Application (2021-2026) & (k units) Table 64. Europe Prescription Arthritis Medications Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Prescription Arthritis Medications Sales by Application (2021-2026) & (k units) Table 66. Asia-Pacific Prescription Arthritis Medications Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Prescription Arthritis Medications Sales by Application (2021-2026) & (k units) Table 68. Latin America Prescription Arthritis Medications Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Prescription Arthritis Medications Sales by Application (2021-2026) & (k units) Table 70. Middle East and Africa Prescription Arthritis Medications Sales by Application (2021-2026) & (US$ Million) Table 71. Boehringer Ingelheim Company Information Table 72. Boehringer Ingelheim Business Overview Table 73. Boehringer Ingelheim Prescription Arthritis Medications Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 74. Boehringer Ingelheim Prescription Arthritis Medications Product Portfolio Table 75. Boehringer Ingelheim Recent Development Table 76. Horizon Pharma Company Information Table 77. Horizon Pharma Business Overview Table 78. Horizon Pharma Prescription Arthritis Medications Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 79. Horizon Pharma Prescription Arthritis Medications Product Portfolio Table 80. Horizon Pharma Recent Development Table 81. Amgen Company Information Table 82. Amgen Business Overview Table 83. Amgen Prescription Arthritis Medications Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 84. Amgen Prescription Arthritis Medications Product Portfolio Table 85. Amgen Recent Development Table 86. Pfizer Company Information Table 87. Pfizer Business Overview Table 88. Pfizer Prescription Arthritis Medications Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 89. Pfizer Prescription Arthritis Medications Product Portfolio Table 90. Pfizer Recent Development Table 91. Novartis Company Information Table 92. Novartis Business Overview Table 93. Novartis Prescription Arthritis Medications Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 94. Novartis Prescription Arthritis Medications Product Portfolio Table 95. Novartis Recent Development Table 96. Abbott Company Information Table 97. Abbott Business Overview Table 98. Abbott Prescription Arthritis Medications Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 99. Abbott Prescription Arthritis Medications Product Portfolio Table 100. Abbott Recent Development Table 101. Regeneron Company Information Table 102. Regeneron Business Overview Table 103. Regeneron Prescription Arthritis Medications Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 104. Regeneron Prescription Arthritis Medications Product Portfolio Table 105. Regeneron Recent Development Table 106. North America Prescription Arthritis Medications Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 107. North America Prescription Arthritis Medications Sales by Country (2021-2026) & (k units) Table 108. North America Prescription Arthritis Medications Sales Market Share by Country (2021-2026) Table 109. North America Prescription Arthritis Medications Sales Forecast by Country (2027-2032) & (k units) Table 110. North America Prescription Arthritis Medications Sales Market Share Forecast by Country (2027-2032) Table 111. North America Prescription Arthritis Medications Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 112. North America Prescription Arthritis Medications Market Size by Country (2021-2026) & (US$ Million) Table 113. North America Prescription Arthritis Medications Market Share by Country (2021-2026) Table 114. North America Prescription Arthritis Medications Market Size Forecast by Country (2027-2032) & (US$ Million) Table 115. North America Prescription Arthritis Medications Market Share Forecast by Country (2027-2032) Table 116. Europe Prescription Arthritis Medications Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 117. Europe Prescription Arthritis Medications Sales by Country (2021-2026) & (k units) Table 118. Europe Prescription Arthritis Medications Sales Market Share by Country (2021-2026) Table 119. Europe Prescription Arthritis Medications Sales Forecast by Country (2027-2032) & (k units) Table 120. Europe Prescription Arthritis Medications Sales Market Share Forecast by Country (2027-2032) Table 121. Europe Prescription Arthritis Medications Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 122. Europe Prescription Arthritis Medications Market Size by Country (2021-2026) & (US$ Million) Table 123. Europe Prescription Arthritis Medications Market Share by Country (2021-2026) Table 124. Europe Prescription Arthritis Medications Market Size Forecast by Country (2027-2032) & (US$ Million) Table 125. Europe Prescription Arthritis Medications Market Share Forecast by Country (2027-2032) Table 126. Asia-Pacific Prescription Arthritis Medications Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 127. Asia-Pacific Prescription Arthritis Medications Sales by Country (2021-2026) & (k units) Table 128. Asia-Pacific Prescription Arthritis Medications Sales Market Share by Country (2021-2026) Table 129. Asia-Pacific Prescription Arthritis Medications Sales Forecast by Country (2027-2032) & (k units) Table 130. Asia-Pacific Prescription Arthritis Medications Sales Market Share Forecast by Country (2027-2032) Table 131. Asia-Pacific Prescription Arthritis Medications Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 132. Asia-Pacific Prescription Arthritis Medications Market Size by Country (2021-2026) & (US$ Million) Table 133. Asia-Pacific Prescription Arthritis Medications Market Share by Country (2021-2026) Table 134. Asia-Pacific Prescription Arthritis Medications Market Size Forecast by Country (2027-2032) & (US$ Million) Table 135. Asia-Pacific Prescription Arthritis Medications Market Share Forecast by Country (2027-2032) Table 136. Latin America Prescription Arthritis Medications Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 137. Latin America Prescription Arthritis Medications Sales by Country (2021-2026) & (k units) Table 138. Latin America Prescription Arthritis Medications Sales Market Share by Country (2021-2026) Table 139. Latin America Prescription Arthritis Medications Sales Forecast by Country (2027-2032) & (k units) Table 140. Latin America Prescription Arthritis Medications Sales Market Share Forecast by Country (2027-2032) Table 141. Latin America Prescription Arthritis Medications Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 142. Latin America Prescription Arthritis Medications Market Size by Country (2021-2026) & (US$ Million) Table 143. Latin America Prescription Arthritis Medications Market Share by Country (2021-2026) Table 144. Latin America Prescription Arthritis Medications Market Size Forecast by Country (2027-2032) & (US$ Million) Table 145. Latin America Prescription Arthritis Medications Market Share Forecast by Country (2027-2032) Table 146. Middle East and Africa Prescription Arthritis Medications Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 147. Middle East and Africa Prescription Arthritis Medications Sales by Country (2021-2026) & (k units) Table 148. Middle East and Africa Prescription Arthritis Medications Sales Market Share by Country (2021-2026) Table 149. Middle East and Africa Prescription Arthritis Medications Sales Forecast by Country (2027-2032) & (k units) Table 150. Middle East and Africa Prescription Arthritis Medications Sales Market Share Forecast by Country (2027-2032) Table 151. Middle East and Africa Prescription Arthritis Medications Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 152. Middle East and Africa Prescription Arthritis Medications Market Size by Country (2021-2026) & (US$ Million) Table 153. Middle East and Africa Prescription Arthritis Medications Market Share by Country (2021-2026) Table 154. Middle East and Africa Prescription Arthritis Medications Market Size Forecast by Country (2027-2032) & (US$ Million) Table 155. Middle East and Africa Prescription Arthritis Medications Market Share Forecast by Country (2027-2032) Table 156. Key Raw Materials Table 157. Raw Materials Key Suppliers Table 158. Prescription Arthritis Medications Distributors List Table 159. Prescription Arthritis Medications Customers List Table 160. Research Programs/Design for This Report Table 161. Authors List of This Report Table 162. Secondary Sources Table 163. Primary Sources List of Figures Figure 1. Prescription Arthritis Medications Image Figure 2. Global Prescription Arthritis Medications Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Prescription Arthritis Medications Market Size (2021-2032) & (US$ Million) Figure 4. Global Prescription Arthritis Medications Sales (2021-2032) & (k units) Figure 5. Oral Image Figure 6. Global Oral Sales YoY Growth (2021-2032) & (k units) Figure 7. Topical Image Figure 8. Global Topical Sales YoY Growth (2021-2032) & (k units) Figure 9. Global Prescription Arthritis Medications Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Prescription Arthritis Medications Market Share by Type 2025 VS 2032 Figure 11. North America Prescription Arthritis Medications Sales Market Share in Volume by Type in 2025 Figure 12. North America Prescription Arthritis Medications Sales Market Share in Value by Type in 2025 Figure 13. Europe Prescription Arthritis Medications Sales Market Share in Volume by Type in 2025 Figure 14. Europe Prescription Arthritis Medications Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Prescription Arthritis Medications Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Prescription Arthritis Medications Sales Market Share in Value by Type in 2025 Figure 17. Latin America Prescription Arthritis Medications Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Prescription Arthritis Medications Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Prescription Arthritis Medications Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Prescription Arthritis Medications Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Prescription Arthritis Medications Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Online Pharmacies Image Figure 24. Global Online Pharmacies Sales YoY Growth (2021-2032) & (k units) Figure 25. Hospital Pharmacies Image Figure 26. Global Hospital Pharmacies Sales YoY Growth (2021-2032) & (k units) Figure 27. Retail Pharmacies Image Figure 28. Global Retail Pharmacies Sales YoY Growth (2021-2032) & (k units) Figure 29. Global Prescription Arthritis Medications Market Size Overview by Application (2021-2032) & (US$ Million) Figure 30. Global Prescription Arthritis Medications Market Share by Application 2025 VS 2032 Figure 31. North America Prescription Arthritis Medications Sales Market Share in Volume by Application in 2025 Figure 32. North America Prescription Arthritis Medications Sales Market Share in Value by Application in 2025 Figure 33. Europe Prescription Arthritis Medications Sales Market Share in Volume by Application in 2025 Figure 34. Europe Prescription Arthritis Medications Sales Market Share in Value by Application in 2025 Figure 35. Asia-Pacific Prescription Arthritis Medications Sales Market Share in Volume by Application in 2025 Figure 36. Asia-Pacific Prescription Arthritis Medications Sales Market Share in Value by Application in 2025 Figure 37. Latin America Prescription Arthritis Medications Sales Market Share in Volume by Application in 2025 Figure 38. Latin America Prescription Arthritis Medications Sales Market Share in Value by Application in 2025 Figure 39. Middle East and Africa Prescription Arthritis Medications Sales Market Share in Volume by Application in 2025 Figure 40. Middle East and Africa Prescription Arthritis Medications Sales Market Share in Value by Application in 2025 Figure 41. North America Prescription Arthritis Medications Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 42. North America Prescription Arthritis Medications Sales Share by Country: 2021 VS 2025 VS 2032 Figure 43. North America Prescription Arthritis Medications Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 44. North America Prescription Arthritis Medications Market Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Prescription Arthritis Medications Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 46. Europe Prescription Arthritis Medications Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Prescription Arthritis Medications Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. Europe Prescription Arthritis Medications Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Prescription Arthritis Medications Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 50. Asia-Pacific Prescription Arthritis Medications Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Prescription Arthritis Medications Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Asia-Pacific Prescription Arthritis Medications Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Prescription Arthritis Medications Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 54. Latin America Prescription Arthritis Medications Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Prescription Arthritis Medications Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Latin America Prescription Arthritis Medications Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Prescription Arthritis Medications Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 58. Middle East and Africa Prescription Arthritis Medications Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Prescription Arthritis Medications Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Middle East and Africa Prescription Arthritis Medications Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Prescription Arthritis Medications Value Chain Figure 62. Key Raw Materials Price Figure 63. Manufacturing Cost Structure Figure 64. Prescription Arthritis Medications Production Mode & Process Figure 65. Direct Comparison with Distribution Share Figure 66. Distributors Profiles Figure 67. Years Considered Figure 68. Research Process Figure 69. Key Executives Interviewed

Scope & coverage.

Types
  • Oral
  • Topical
Applications
  • Online Pharmacies
  • Hospital Pharmacies
  • Retail Pharmacies
Companies covered
  • Boehringer Ingelheim
  • Horizon Pharma
  • Amgen
  • Pfizer
  • Novartis
  • Abbott
  • Regeneron

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Prescription Arthritis Medications Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Prescription Arthritis Medications Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Prescription Arthritis Medications Market by Type
  6. 1.3.1 Oral
  7. 1.3.2 Topical
  8. 1.4 Global Prescription Arthritis Medications Market Size by Type
  9. 1.4.1 Global Prescription Arthritis Medications Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Prescription Arthritis Medications Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Prescription Arthritis Medications Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Prescription Arthritis Medications Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Prescription Arthritis Medications Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Prescription Arthritis Medications Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Prescription Arthritis Medications Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Prescription Arthritis Medications Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Prescription Arthritis Medications Industry Trends
  2. 2.2 Prescription Arthritis Medications Industry Drivers
  3. 2.3 Prescription Arthritis Medications Industry Opportunities and Challenges
  4. 2.4 Prescription Arthritis Medications Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Prescription Arthritis Medications Revenue (2021-2026)
  2. 3.2 Global Top Players by Prescription Arthritis Medications Sales (2021-2026)
  3. 3.3 Global Top Players by Prescription Arthritis Medications Price (2021-2026)
  4. 3.4 Global Prescription Arthritis Medications Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Prescription Arthritis Medications Major Company Production Sites & Headquarters
  6. 3.6 Global Prescription Arthritis Medications Company, Product Type & Application
  7. 3.7 Global Prescription Arthritis Medications Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Prescription Arthritis Medications Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Prescription Arthritis Medications Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Prescription Arthritis Medications Tier 1, Tier 2, and Tier 3
4 Prescription Arthritis Medications Regional Status and Outlook
  1. 4.1 Global Prescription Arthritis Medications Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Prescription Arthritis Medications Historic Market Size by Region
  3. 4.2.1 Global Prescription Arthritis Medications Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Prescription Arthritis Medications Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Prescription Arthritis Medications Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Prescription Arthritis Medications Forecasted Market Size by Region
  7. 4.3.1 Global Prescription Arthritis Medications Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Prescription Arthritis Medications Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Prescription Arthritis Medications Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Prescription Arthritis Medications by Application
  1. 5.1 Prescription Arthritis Medications Market by Application
  2. 5.1.1 Online Pharmacies
  3. 5.1.2 Hospital Pharmacies
  4. 5.1.3 Retail Pharmacies
  5. 5.2 Global Prescription Arthritis Medications Market Size by Application
  6. 5.2.1 Global Prescription Arthritis Medications Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Prescription Arthritis Medications Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Prescription Arthritis Medications Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Prescription Arthritis Medications Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Prescription Arthritis Medications Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Prescription Arthritis Medications Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Prescription Arthritis Medications Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Prescription Arthritis Medications Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Boehringer Ingelheim
  2. 6.1.1 Boehringer Ingelheim Company Information
  3. 6.1.2 Boehringer Ingelheim Business Overview
  4. 6.1.3 Boehringer Ingelheim Prescription Arthritis Medications Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Boehringer Ingelheim Prescription Arthritis Medications Product Portfolio
  6. 6.1.5 Boehringer Ingelheim Recent Developments
  7. 6.2 Horizon Pharma
  8. 6.2.1 Horizon Pharma Company Information
  9. 6.2.2 Horizon Pharma Business Overview
  10. 6.2.3 Horizon Pharma Prescription Arthritis Medications Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Horizon Pharma Prescription Arthritis Medications Product Portfolio
  12. 6.2.5 Horizon Pharma Recent Developments
  13. 6.3 Amgen
  14. 6.3.1 Amgen Company Information
  15. 6.3.2 Amgen Business Overview
  16. 6.3.3 Amgen Prescription Arthritis Medications Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Amgen Prescription Arthritis Medications Product Portfolio
  18. 6.3.5 Amgen Recent Developments
  19. 6.4 Pfizer
  20. 6.4.1 Pfizer Company Information
  21. 6.4.2 Pfizer Business Overview
  22. 6.4.3 Pfizer Prescription Arthritis Medications Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Pfizer Prescription Arthritis Medications Product Portfolio
  24. 6.4.5 Pfizer Recent Developments
  25. 6.5 Novartis
  26. 6.5.1 Novartis Company Information
  27. 6.5.2 Novartis Business Overview
  28. 6.5.3 Novartis Prescription Arthritis Medications Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Novartis Prescription Arthritis Medications Product Portfolio
  30. 6.5.5 Novartis Recent Developments
  31. 6.6 Abbott
  32. 6.6.1 Abbott Company Information
  33. 6.6.2 Abbott Business Overview
  34. 6.6.3 Abbott Prescription Arthritis Medications Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Abbott Prescription Arthritis Medications Product Portfolio
  36. 6.6.5 Abbott Recent Developments
  37. 6.7 Regeneron
  38. 6.7.1 Regeneron Company Information
  39. 6.7.2 Regeneron Business Overview
  40. 6.7.3 Regeneron Prescription Arthritis Medications Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Regeneron Prescription Arthritis Medications Product Portfolio
  42. 6.7.5 Regeneron Recent Developments
7 North America by Country
  1. 7.1 North America Prescription Arthritis Medications Sales by Country
  2. 7.1.1 North America Prescription Arthritis Medications Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Prescription Arthritis Medications Sales by Country (2021-2026)
  4. 7.1.3 North America Prescription Arthritis Medications Sales Forecast by Country (2027-2032)
  5. 7.2 North America Prescription Arthritis Medications Market Size by Country
  6. 7.2.1 North America Prescription Arthritis Medications Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Prescription Arthritis Medications Market Size by Country (2021-2026)
  8. 7.2.3 North America Prescription Arthritis Medications Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Prescription Arthritis Medications Sales by Country
  2. 8.1.1 Europe Prescription Arthritis Medications Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Prescription Arthritis Medications Sales by Country (2021-2026)
  4. 8.1.3 Europe Prescription Arthritis Medications Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Prescription Arthritis Medications Market Size by Country
  6. 8.2.1 Europe Prescription Arthritis Medications Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Prescription Arthritis Medications Market Size by Country (2021-2026)
  8. 8.2.3 Europe Prescription Arthritis Medications Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Prescription Arthritis Medications Sales by Country
  2. 9.1.1 Asia-Pacific Prescription Arthritis Medications Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Prescription Arthritis Medications Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Prescription Arthritis Medications Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Prescription Arthritis Medications Market Size by Country
  6. 9.2.1 Asia-Pacific Prescription Arthritis Medications Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Prescription Arthritis Medications Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Prescription Arthritis Medications Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Prescription Arthritis Medications Sales by Country
  2. 10.1.1 South America Prescription Arthritis Medications Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Prescription Arthritis Medications Sales by Country (2021-2026)
  4. 10.1.3 South America Prescription Arthritis Medications Sales Forecast by Country (2027-2032)
  5. 10.2 South America Prescription Arthritis Medications Market Size by Country
  6. 10.2.1 South America Prescription Arthritis Medications Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Prescription Arthritis Medications Market Size by Country (2021-2026)
  8. 10.2.3 South America Prescription Arthritis Medications Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Prescription Arthritis Medications Sales by Country
  2. 11.1.1 Middle East and Africa Prescription Arthritis Medications Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Prescription Arthritis Medications Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Prescription Arthritis Medications Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Prescription Arthritis Medications Market Size by Country
  6. 11.2.1 Middle East and Africa Prescription Arthritis Medications Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Prescription Arthritis Medications Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Prescription Arthritis Medications Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Prescription Arthritis Medications Value Chain Analysis
  2. 12.1.1 Prescription Arthritis Medications Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Prescription Arthritis Medications Production Mode & Process
  7. 12.2 Prescription Arthritis Medications Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Prescription Arthritis Medications Distributors
  10. 12.2.3 Prescription Arthritis Medications Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst